🔬
Foundation Sciences · Biochemistry

Pyrimidine Metabolism

⏱️ 45–60 minutes read 📖 Biochemistry

Synthesis of cytosine, thymine, uracil from carbamoyl phosphate and aspartate; degradation to soluble products.

📌 Learning Objectives

  • Describe the key principles of pyrimidine metabolism.
  • Explain the clinical relevance of pyrimidine metabolism.
  • Recognise common conditions linked to pyrimidine metabolism in MLA-style scenarios.

📋 Overview

Synthesis of cytosine, thymine, uracil from carbamoyl phosphate and aspartate; degradation to soluble products. This topic integrates with pathology, pharmacology and clinical medicine and is frequently tested in UK medical school exams and the MLA.

🔬 Basic Science

Synthesis of cytosine, thymine, uracil from carbamoyl phosphate and aspartate; degradation to soluble products. Detailed mechanisms, regulation and molecular interactions underpin both normal physiology and disease.

🏥 Clinical Relevance

5-FU chemotherapy; orotic aciduria treated with uridine.

🧪 Investigations

Relevant laboratory tests, imaging or histological examination are used as appropriate to the clinical context.

💊 Management

Management is condition-specific; principles include addressing the underlying biochemical/structural derangement, supportive care and targeted therapy where available.

Revision Resources – expand the sections below for high-yield notes, exam pearls, key facts and further reading.

🎯 MLA High-Yield Notes & Quick Revision ⌄
High-yield topic for the UK MLA — frequently appears in SBA questions linking biochemistry concepts to clinical presentations and management decisions.
Applying biomedical science to clinical practice Diagnosis and investigation Pathophysiology of common conditions
  • Synthesis of cytosine, thymine, uracil from carbamoyl phosphate and aspartate
  • degradation to soluble products.
⭐ Exam Pearls ⌄
⭐ High Yield
CAD complex (CPS-II, ATCase, dihydroorotase) cytosolic
5-FU inhibits thymidylate synthase
Orotic aciduria: UMP synthase deficiency
Distinguish from OTC deficiency (no hyperammonaemia)
💡 Clinical Pearl
: 5-FU chemotherapy; orotic aciduria treated with uridine.
⚠️ Exam Tip — Common Mistakes
Confusing pyrimidine metabolism with related but distinct mechanisms.
Memorising pathways without linking to clinical disease.
🔑 Key Facts ⌄
CAD complex (CPS-II, ATCase, dihydroorotase) cytosolic
5-FU inhibits thymidylate synthase
Orotic aciduria: UMP synthase deficiency
Distinguish from OTC deficiency (no hyperammonaemia)
📚 References ⌄
  1. BMJ Best Practice
  2. Robbins Basic Pathology
  3. Lippincott Illustrated Reviews: Biochemistry
  4. Wheater's Functional Histology
  5. NICE guidance where applicable.

Further Resources

Medical Portfolio & Career Development

Build a professional portfolio website for applications, audits, teaching, research and career progression.

CVtoWebsite.com →